RE-configuring MEDIcines End-to-end Supply (REMEDIES)

At a Glance
  • Status: Active Consortium
  • Year Launched: 2014
  • Initiating Organization: GlaxoSmithKline
  • Initiator Type: Industry
  • No disease focus
  • Location: Europe


The REMEDIES (RE-configuring MEDIcines End-to-end Supply) project, launched in 2014, is headed up by GlaxoSmithKline (GSK) with research led by the University of Cambridge’s Institute for Manufacturing. It brings together key players in the end-to-end supply chain, including major contract manufacturing organizations, equipment manufacturers along with regulators, knowledge transfer networks, and healthcare providers.


To provide a better service to patients and to safeguard jobs across the UK, the consortium has several technology-based application projects underpinned by two platform projects: clinical trials supply chains, led by GSK, and commercial supply chains led by IfM. The project involves several inter-related application work streams.

Consortium History

For current and past news of the REMEDIES Consortium, click here

Structure & Governance

The REMEDIES Consortium was developed by GlaxoSmithKline with research being led by the University of Cambridge’s Institute of Manufacturing.


The consortium is funded with government money and industry contributions

Points of Contact

Dr. Ettore Settanni, University of Cambridge

Sponsors & Partners



University of Cambridge, Institute of Manufacturing

University of Strathclyde


Robinsons Brothers

C-Tech Innovation

Cambridge Reactor Design

Alconbury Weston Ltd



The Centre for Process Innovation


Perceptive Engineering




GEA Processing Engineering


Process Systems Engineering (PSE)

Juniper Pharmaceuticals

Last Updated: 06/27/2017

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.